PCNA |
PCNA: Proliferating cell nuclear antigen |
CDK2 |
CDK2: Cell division protein kinase 2 |
32.910 |
Evidence |
O
|
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
32.910 |
Evidence |
|
OXSR1 |
OXSR1, KIAA1101, OSR1: Serine/threonine-protein kinase OSR1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
32.910 |
Evidence |
|
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
32.910 |
Evidence |
|
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
32.910 |
Evidence |
|
OXSR1 |
OXSR1, KIAA1101, OSR1: Serine/threonine-protein kinase OSR1 |
NUP153 |
IPI00514528 |
32.910 |
Evidence |
|
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
CHAF1B |
CHAF1B, CAF1A, CAF1P60, MPHOSPH7, MPP7: Chromatin assembly factor 1 subunit B |
32.910 |
Evidence |
|
WASPIP |
IPI00552369 |
RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
32.910 |
Evidence |
|
SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
NUP153 |
IPI00514528 |
32.910 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
32.910 |
Evidence |
|
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
NPM1 |
NPM1, NPM: Nucleophosmin |
32.910 |
Evidence |
|
SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
ANAPC5 |
ANAPC5, APC5: Anaphase-promoting complex subunit 5 |
32.910 |
Evidence |
|
ANAPC5 |
ANAPC5, APC5: Anaphase-promoting complex subunit 5 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
32.910 |
Evidence |
|
CDK4 |
CDK4: Cell division protein kinase 4 |
MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
32.910 |
Evidence |
|
GRAP |
GRAP: GRB2-related adapter protein |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
32.900 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
32.900 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
32.900 |
Evidence |
|
BIRC3 |
BIRC3, API2, IAP1, MIHC, RNF49: Baculoviral IAP repeat-containing protein 3 |
BIRC2 |
BIRC2, API1, IAP2, MIHB, RNF48: Baculoviral IAP repeat-containing protein 2 |
32.900 |
Evidence |
|
PDCD6IP |
PDCD6IP, AIP1, ALIX, KIAA1375: Programmed cell death 6-interacting protein |
CHMP4C |
CHMP4C, SHAX3: Charged multivesicular body protein 4c |
32.860 |
Evidence |
O
|
PDCD6IP |
PDCD6IP, AIP1, ALIX, KIAA1375: Programmed cell death 6-interacting protein |
CHMP4B |
CHMP4B, C20orf178, SHAX1: Charged multivesicular body protein 4b |
32.860 |
Evidence |
O
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
32.850 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
32.850 |
Evidence |
|
SRF |
SRF: Serum response factor |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
32.840 |
Evidence |
|
PLD2 |
PLD2: Phospholipase D2 |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
32.840 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
IQSEC1 |
IQSEC1, ARFGEP100, BRAG2, KIAA0763: IQ motif and Sec7 domain-containing protein |
32.840 |
Evidence |
|